סינתרואיד 50 מקג טבליות Israel - hebraico - Ministry of Health

סינתרואיד 50 מקג טבליות

abbott medical laboratories ltd, israel - levothyroxine sodium - טבליה - levothyroxine sodium 50 mcg - levothyroxine sodium - levothyroxine sodium - hypothyroidism, pituitary tsh suppression

יוטירוקס 50 מקג Israel - hebraico - Ministry of Health

יוטירוקס 50 מקג

merck serono ltd - levothyroxine sodium - טבליה - levothyroxine sodium 50 mcg - levothyroxine sodium - levothyroxine sodium - euthyrox 25 - 200 microgram :- treatment of benign euthyroid goitre.- prophylaxis of relapse after surgery for euthyroid goitre, depending on the post - operative hormone status.- substitution therapy in hypothyroidism.- suppression therapy in thyroid cancer.euthyrox 25 - 100 microgram :- concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism.euthyrox 100/150/200 microgram :- diagnostic use for thyroid suppression testing.

יוטירוקס 100 מקג Israel - hebraico - Ministry of Health

יוטירוקס 100 מקג

merck serono ltd - levothyroxine sodium - טבליה - levothyroxine sodium 100 mcg - levothyroxine sodium - levothyroxine sodium - euthyrox 25 - 200 microgram :- treatment of benign euthyroid goitre.- prophylaxis of relapse after surgery for euthyroid goitre, depending on the post - operative hormone status.- substitution therapy in hypothyroidism.- suppression therapy in thyroid cancer.euthyrox 25 - 100 microgram :- concomitant supplementation during anti-thyroid drug treatment of hyperthyroidism.euthyrox 100/150/200 microgram :- diagnostic use for thyroid suppression testing.

טאבניק  500 מג תמיסה לאינפוזיה תוך ורידית Israel - hebraico - Ministry of Health

טאבניק 500 מג תמיסה לאינפוזיה תוך ורידית

sanofi - aventis israel ltd - levofloxacin as hemihydrate - תמיסה לאינפוזיה - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

סטאלבו 12531.25200 מג Israel - hebraico - Ministry of Health

סטאלבו 12531.25200 מג

inovamed pharma ltd, israel - carbidopa as monohydrate; entacapone; levodopa - טבליות מצופות פילם - levodopa 125 mg; entacapone 200 mg; carbidopa as monohydrate 31.25 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa/decarboxylase (ddc) inhibitor treatment.

סטאלבו   15037.5200 מג Israel - hebraico - Ministry of Health

סטאלבו 15037.5200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 150 mg; carbidopa 37.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

סינמט CR Israel - hebraico - Ministry of Health

סינמט cr

organon pharma israel ltd., israel - carbidopa as monohydrate; levodopa - טבליות בשחרור מבוקר - levodopa 200 mg; carbidopa as monohydrate 50 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - idiopathic parkinson's disease. postencephalitic parkinsonism. symptomatic parkinsonism. to reduce "off" time in patients previously treated with levodopa/decarboxylase inhibitor preparations, or with levodopa alone, who have had motor fluctuations characterized by end-of-dose deterioration ("wearing-off" phenomenon), peak dose dyskinesias, akinesia, or similar evidence of short-duration motor disturbances.

סטאלבו 7518.75200 מג Israel - hebraico - Ministry of Health

סטאלבו 7518.75200 מג

inovamed pharma ltd, israel - carbidopa as monohydrate; entacapone; levodopa - טבליות מצופות פילם - carbidopa as monohydrate 18.75 mg; entacapone 200 mg; levodopa 75 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa/decarboxylase (ddc) inhibitor treatment.

מירנה Israel - hebraico - Ministry of Health

מירנה

bayer israel ltd - levonorgestrel - התקן תוך רחמי - levonorgestrel 52 mg - levonorgestrel and estrogen - levonorgestrel and estrogen - contraception and idiopathic menorrhagia. protection from endometrial hyperplasia during estrogen replacement therapy.

נורלבו 0.75 מג Israel - hebraico - Ministry of Health

נורלבו 0.75 מג

cts ltd - levonorgestrel - טבליה - levonorgestrel 0.75 mg - levonorgestrel - levonorgestrel - emergency contraceptive.